Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity

Virology

Volumn 289, Issue 2, 2001, Pages 378-387

  Liu, Yong ^a   Wolff, Karen C ^a   Jacobs, Bertram L ^b   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; INTERFERON; PROTEIN E3L; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN RNA BINDING; RNA EDITING; VACCINIA VIRUS; VIRUS RESISTANCE;

VACCINIA; VACCINIA VIRUS;

EID: 0035950596     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1154     Document Type: Article

References (60)

1. RNA editing and hypermutation by adenosine deamination
2. A standardized nomenclature for adenosine deaminases that act on RNA
3. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene
4. Vaccinia virus-encoded elF-2 alpha homolog abrogates the antiviral effect of interferon
5. Binding of the protein kinase PKR to RNAs with secondary structure defects: Role of the tandem A-G mismatch and noncontiguous helixes
6. Interferons and other cytokines
7. Beth carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model
8. The Z-α domain of the editing enzyme dsRNA adenosine deaminase binds left-handed Z-RNA as well as Z-DNA
9. Regulation of serotonin-2C receptor G-protein coupling by RNA editing
10. Biased (A → I) hypermutation of animal RNA virus genomes
11. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections
12. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA
13. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L
14. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
15. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms
16. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter
17. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible
18. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase
19. Proteins that interact with PKR
20. Editing of messenger RNA precursors and of tRNAs by adenosine to inosine conversion
21. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing
22. The αβ domain of the human RNA editing enzyme ADAR1 recognizes Z-DNA when surrounded by B-DNA
23. Virus-host cell interactions
24. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts
25. The molecular biology of hepatitis delta virus
26. Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase
27. Mechanism of interferon action: Functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase
28. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1
29. Functionally distinct double-stranded RNA-binding domains associated with alternative splice-site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase
30. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1
31. Double-stranded RNA-specific adenosine deaminase. Nucleic acid binding properties
32. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR
33. High efficiency polyoma DNA transfection of chloroquine-treated cells
34. Changing genetic information through RNA editings
35. Adenovirus virus-associated RNA and translational control
36. Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: Identification of a repeated basic amino acid motif within the C-terminal binding region
37. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA
38. Biosynthesis of reovirus-specified polypeptides: Effect of point mutation of the sequences flanking the 5′-proximal AUG initiator codons of the reovirus S1 and S4 genes on the efficiency of mRNA translation
39. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase
40. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity
41. Expression and regulation by interferon of a double-stranded RNA-specific adenosine deaminase from human cells: Evidence for two forms of the deaminase
42. Mechanism of interferon action. Doubre-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons
43. RNA editing generates a diverse array of transcripts encoding squid Ky2 K+ channels with altered functional properties
44. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA
45. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase
46. The human 2′,5′-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties
47. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme
48. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: Role of complex formation, and the E3 N-terminal domain
49. Regulation of alternative splicing by RNA editing
50. Mechanism of interferon action. Phosphorylation of protein synthesis initiation factor elF-2 in interferon-treated human cells by a ribosome-associated protein kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase
51. Antiviral actions of interferons
52. A ribonuclease specific for inosine-containing RNA: A potential role in antiviral defense?
53. RNA editing of brain glutamate receptor channels: Mechanism and physiology
54. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: Implication for PKR autoregulation
55. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha
56. Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L
57. Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis
58. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase
59. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures
60. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene